Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease

INTRODUCTION: Study outcomes can be measured repeatedly based on the clinical trial protocol before randomization during what is known as the “run-in” period. However, it has not been established how best to incorporate run-in data into the primary analysis of the trial. METHODS: We proposed two-per...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guoqiao, Aschenbrenner, Andrew J., Li, Yan, McDade, Eric, Liu, Lei, Benzinger, Tammie L.S., Bateman, Randall J., Morris, John C., Hassenstab, Jason J., Xiong, Chengjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732759/
https://www.ncbi.nlm.nih.gov/pubmed/31517032
http://dx.doi.org/10.1016/j.trci.2019.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732759/
https://www.ncbi.nlm.nih.gov/pubmed/31517032
http://dx.doi.org/10.1016/j.trci.2019.07.007

Ejemplares similares